Press release
Elevated Rates Of Obesity And Heart Disease Fuel Expansion Of The Type 2 Diabetes Market: Pivotal Factor Influencing Type 2 Diabetes Market Growth in 2025
Type 2 Diabetes Market Size
Type 2 Diabetes Market Size Growth Forecast: What to Expect by 2025?
The market size for type 2 diabetes has seen substantial growth in recent years. The progression is expected to continue, with the value escalating from $48.14 billion in 2024 to $51.96 billion in 2025, charting a compound annual growth rate (CAGR) of 7.9%. Factors contributing to the historic growth include lifestyle and shifts, an aging populace, advancements in pharmaceuticals, and public health campaigns.
How Will the Type 2 Diabetes Market Size Evolve and Grow by 2029?
The market for type 2 diabetes is anticipated to witness substantial expansion in the coming years. By 2029, it is projected to reach $72.22 billion, growing at a compound annual growth rate (CAGR) of 8.6%. The predicted growth over the forecast period could be due to the global diabetes epidemic, personalized medicine, strides in technology, and alterations in healthcare policies. Key trends during this forecast period are expected to be digital health and telemedicine, proactive prevention and early intervention, as well as artificial intelligence (AI) and machine learning (ML), and metabolic surgery.
View the full report here:
https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report
What Drivers Are Propelling the Growth of Type 2 Diabetes Market Forward?
The progression of the type 2 diabetes market is projected to be steered by escalating rates of obesity and heart disease. Obesity, characterized by an unhealthy accumulation of excessive body fat, and heart disease, encompassing varying conditions impacting the heart and blood vessels, are significant contributors. An increase in body weight elevates the risk of insulin resistance, causing elevated blood sugar levels and stimulating the onset of type 2 diabetes. Simultaneously, heightened blood sugar levels can lead to damage to blood vessels and nerves governing the heart and blood vessels, thereby provoking heart disease. As evidence, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, declared in March 2024 that about one-eighth of the global population was grappling with obesity. This encompassed 2.5 billion adults (18 years and older), with 890 million among them afflicted with obesity. While 43% of adults were overweight, 16% were categorized as obese. The count of overweight children below five years stood at 37 million. Consequently, the escalating prevalence of obesity and heart disease is fuelling the expansion of the type 2 diabetes market. Rising geriatric population propels type 2 diabetes market growth
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13050&type=smp
Which Emerging Trends Are Transforming the Type 2 Diabetes Market in 2025?
Leading corporations in the type 2 diabetes market are concentrating on the creation of innovative products, like Mounjaro, to raise the bar for safety and efficacy for those suffering from diabetes. Groundbreaking medications like Mounjaro are intended to improve the performance, safety, or simplicity of managing diabetes in comparison to traditional drugs. The focal points of diabetes medicine advancements are better blood sugar regulation, reduction in side effects and addressing associated health issues. In May 2022, for example, Eli Lilly and Co., a US-based pharmaceutical firm, was granted approval from the U.S. Food and Drug Administration, an American government agency, for the use of Mounjaro (tripeptide) injection to aid blood sugar management in adults with type 2 diabetes, in combination with a suitable diet and exercise. Tirzepatide is a novel, dual-action drug for type 2 diabetes, administered through a once-weekly injection that targets two hormones, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which are vital in blood sugar regulation. GLP-1 aids in boosting insulin production and decreasing glucagon production, while GIP has a similar effect on insulin production. Tirzepatide showcases potential as an appealing new treatment alternative for individuals with type 2 diabetes, even those who have previously not seen results from other treatments.
What Are the Key Segments in the Type 2 Diabetes Market?
The type 2 diabetes market covered in this report is segmented -
1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Other Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes
2) By Application: Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications
3) By End-User: Children, Adults
Subsegments:
1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide, Semaglutide, Dulaglutide, Exenatide
3) By Thiazolidinediones: Pioglitazone, Rosiglitazone
4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol
5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride, Glipizide, Glyburide
6) By Biguanides: Metformin
7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin
8) By Other Drug Classes: Amylin Analogues, Bile Acid Sequestrants, Dopamine Agonists
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13050&type=smp
Who Are the Key Players Shaping the Type 2 Diabetes Market's Competitive Landscape?
Major companies operating in the type 2 diabetes market are F. Hoffmann-La Roche AG, Merck and Co. Inc., Novartis AG, AstraZeneca PLC, Abbott Laboratories, Sanofi SA, Medtronic PLC, Takeda Pharmaceutical Company, GlaxoSmithKline plc., Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Dexcom Inc., Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Byram Healthcare, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health.
What Geographic Markets Are Powering Growth in the Type 2 Diabetes Market?
North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13050
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Elevated Rates Of Obesity And Heart Disease Fuel Expansion Of The Type 2 Diabetes Market: Pivotal Factor Influencing Type 2 Diabetes Market Growth in 2025 here
News-ID: 4128965 • Views: …
More Releases from The Business Research Company
Accelerated Digital Transformation Fuels Expansion in the Smart Ferry Electrific …
How Much Is the Smart Ferry Electrification Market Expected to Expand by 2025?
The sphere of smart ferry electrification has witnessed swift expansion lately, projected to advance from a valuation of $1.24 billion in 2024 to $1.42 billion in 2025, demonstrating a compound annual growth rate (CAGR) calculated at 14.9%. This expansion across the historical timeframe is linked to several key factors, including the increasing availability of governmental support and financial…
2025-2034 Single Port DC Wallbox Charger Market Evolution: Emerging Opportunitie …
What Is the Projected Size of the Single Port DC Wallbox Charger Market by 2025?
The market scope for single-port DC wallbox chargers has seen substantial recent expansion; specifically, its valuation is projected to increase from $1.03 billion in 2024 to reach $1.22 billion by 2025, reflecting a compound annual growth rate of 17.9%. This historical upswing is primarily driven by surging electric vehicle sales across the globe, the increasing deployment…
Shelf Image Recognition Artificial Intelligence Market Poised for Robust Growth, …
How Much Is the Shelf Image Recognition Artificial Intelligence Market Expected to Expand by 2025?
The artificial intelligence market focused on recognizing items on shelves has experienced a remarkable surge lately; this segment is projected to expand from generating $1.43 billion in 2024 to reaching $1.82 billion in 2025, reflecting an impressive compound annual growth rate of 26.8%. This substantial expansion observed during the past period stems from several key factors,…
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Lea …
The nano antibodies market is gaining significant attention due to its promising applications in precision medicine and targeted therapies. With rapid advancements in biotechnology and increasing research efforts, this market is poised for considerable expansion in the coming years. Let's explore the current market valuation, key drivers, leading companies, and emerging trends shaping this dynamic sector.
Projected Growth and Market Size of the Nano Antibodies Market
The nano antibodies market is anticipated…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
